Evidence map›Paper›PMID 29594915›Full record

Observational studyJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2019

Role of cardiac

Giuseppe De Vincentis, Viviana Frantellizzi, Francesco Fedele, Alessio Farcomeni, Paola Scarparo, Nicolò Salvi, Danilo Alunni Fegatelli, Massimo Mancone, Derk O Verschure, Hein J Verberne

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. The prognostic value ofJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Pooled it
  2. Establishment of aAnnals of nuclear medicine · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. CardiacPharmaceuticals (Basel, Switzerland) · 2022
    Review
  10. Importance of individual patient characteristics when assessing the ability of cardiac adrenergic imaging to guide ICD use.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Article
  11. Prediction of appropriate ICD therapy in patients with ischemic heart failure.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Article
  12. Machine learning-based risk model usingJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Article
  13. Left ventricular hypertrophy caused by arterial hypertension and degenerative aortic stenosis: How usefulJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Article
  14. Article
  15. The utility of heart-to-mediastinum ratio using a planar image created from IQ-SPECT with Iodine-123 meta-iodobenzylguanidine.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  16. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  17. Quality and utility of [Annals of nuclear medicine · 2021
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Giuseppe De VincentisDepartment of Radiological Sciences, Oncology and Anatomo-Pathology, Sapienza - University of Rome, Rome, Italy.
Viviana FrantellizziDepartment of Radiological Sciences, Oncology and Anatomo-Pathology, Sapienza - University of Rome, Rome, Italy.
Francesco FedeleDepartment of Cardiovascular, Respiratory, Nephrology, Anesthesiology and Geriatric Sciences, Sapienza - University of Rome, Rome, Italy.
Alessio FarcomeniDepartment of Public Health and Infectious Diseases, Sapienza - University of Rome, Rome, Italy.
Paola ScarparoDepartment of Cardiovascular, Respiratory, Nephrology, Anesthesiology and Geriatric Sciences, Sapienza - University of Rome, Rome, Italy.
Nicolò SalviDepartment of Cardiovascular, Respiratory, Nephrology, Anesthesiology and Geriatric Sciences, Sapienza - University of Rome, Rome, Italy.
Danilo Alunni FegatelliDepartment of Public Health and Infectious Diseases, Sapienza - University of Rome, Rome, Italy.
Massimo ManconeDepartment of Cardiovascular, Respiratory, Nephrology, Anesthesiology and Geriatric Sciences, Sapienza - University of Rome, Rome, Italy.
Derk O VerschureDepartment of Cardiology, Zaans Medical Center, Zaandam, The Netherlands. d.o.verschure@amc.uva.nl.
Hein J VerberneDepartment of Radiology and Nuclear Medicine, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Sapienza University of Rome · ITUniversity of Amsterdam · NLZaans Medisch Centrum · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite therapeutic improvement, the prognosis of chronic heart failure (CHF) remains unfavorable partly due to arrhythmia and sudden cardiac death (SCD). This prospective study evaluated myocardial

methods170 CHF patients referred for implantable cardioverter-defibrillator (ICD) implantation for both primary and secondary prevention were enrolled. All patients underwent planar and SPECT imaging. Early and late heart-to-mediastinum (H/M) ratio,

resultsDuring a median follow-up of 23.3 months, 69 patients experienced an AE. Early summed score (ESS) was the only independent predictor of AE [HR 1.023 (1.003-1.043)]. Focussing on only patients with an ICD for primary prevention, ESS was the only independent predictor of AE [HR 1.028 (1.007-1.050)].

conclusionAlthough SPECT

Indexed as

Defibrillators, Implantable3-IodobenzylguanidineAgedArrhythmias, CardiacChronic DiseaseFemaleHeartHeart FailureHumansMaleMiddle AgedObserver VariationProspective StudiesRadionuclide ImagingSecondary PreventionTomography, Emission-Computed, Single-Photon3-Iodobenzylguanidine123I-mIBG scintigraphychronic heart failureheart-to-mediastinum ratioICDplanarSPECTwashout

Identifiers

PMID29594915
PMCPMC6660500
OpenAlexW2794619597

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.